Cargando…

Supportive Care in Hematology

Patients with hematological malignancies such as leukemias and lymphomas are predisposed to a wide spectrum of infections that need special attention. These patients are immunosuppressed not only as a result of the immune defects associated with the underlying disease, but also because of the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiemenz, John, Munker, Reinhold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153764/
http://dx.doi.org/10.1007/978-1-59745-149-9_3
_version_ 1783521706471587840
author Hiemenz, John
Munker, Reinhold
author_facet Hiemenz, John
Munker, Reinhold
author_sort Hiemenz, John
collection PubMed
description Patients with hematological malignancies such as leukemias and lymphomas are predisposed to a wide spectrum of infections that need special attention. These patients are immunosuppressed not only as a result of the immune defects associated with the underlying disease, but also because of the treatment regimens that generally further decrease the patient’s resistance to infections. An intensive transfusion support with platelets, red cell concentrates, immunoglobulins, cytokines, and other drugs is necessary. Many patients also need antiemetic agents, nutritional support, pain medication, and, very often, venous catheters. All of these measures are considered supportive care and apply in a similar fashion to the high-dose treatment of solid tumors. Supportive care measures, along with the treatment and prophylaxis of infections, are discussed in this chapter. Transfusion support is discussed in Chapter 22.
format Online
Article
Text
id pubmed-7153764
institution National Center for Biotechnology Information
language English
publishDate 2007
record_format MEDLINE/PubMed
spelling pubmed-71537642020-04-14 Supportive Care in Hematology Hiemenz, John Munker, Reinhold Modern Hematology Article Patients with hematological malignancies such as leukemias and lymphomas are predisposed to a wide spectrum of infections that need special attention. These patients are immunosuppressed not only as a result of the immune defects associated with the underlying disease, but also because of the treatment regimens that generally further decrease the patient’s resistance to infections. An intensive transfusion support with platelets, red cell concentrates, immunoglobulins, cytokines, and other drugs is necessary. Many patients also need antiemetic agents, nutritional support, pain medication, and, very often, venous catheters. All of these measures are considered supportive care and apply in a similar fashion to the high-dose treatment of solid tumors. Supportive care measures, along with the treatment and prophylaxis of infections, are discussed in this chapter. Transfusion support is discussed in Chapter 22. 2007 /pmc/articles/PMC7153764/ http://dx.doi.org/10.1007/978-1-59745-149-9_3 Text en © Humana Press Inc., Totowa, NJ 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Hiemenz, John
Munker, Reinhold
Supportive Care in Hematology
title Supportive Care in Hematology
title_full Supportive Care in Hematology
title_fullStr Supportive Care in Hematology
title_full_unstemmed Supportive Care in Hematology
title_short Supportive Care in Hematology
title_sort supportive care in hematology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153764/
http://dx.doi.org/10.1007/978-1-59745-149-9_3
work_keys_str_mv AT hiemenzjohn supportivecareinhematology
AT munkerreinhold supportivecareinhematology